Publications by authors named "Christopher L Parks"

Claim this Profile
S
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.
Elissa Malkin, Marija Zaric, Mark Kieh, Lindsey R Baden, David Fitz-Patrick, Christopher L Parks

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Intranasal Challenge Model in African Green Monkeys () for Mild-to-Moderate COVID-19 Disease Caused by Subvariant XBB.1.5.
Nadia Storm, Ming Lo, Nicholas Crossland, Margaux Seyler-Schmidt, Hilary Staples, Christopher L Parks

Viruses· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials.
Christopher L Cooper, Gavin Morrow, Maoli Yuan, Thomas S Postler, Maxwell L Neal, Christopher L Parks

EBioMedicine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the antibody response to Lassa virus vaccination of non-human primates.
Adrian S Enriquez, Ruben Diaz Avalos, Diptiben Parekh, Christopher L Cooper, Gavin Morrow, Christopher L Parks

EBioMedicine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute-phase innate immune responses in SIVmac239-infected Indian rhesus macaques may contribute to the establishment of elite control.
Brandon C Rosen, Kaitlin Sawatzki, Michael J Ricciardi, Elise Smith, Inah Golez, Christopher L Parks

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An introduction to the Marburg virus vaccine consortium, MARVAC.
Robert W Cross, Ira M Longini, Stephan Becker, Karin Bok, David Boucher, Christopher L Parks

PLoS Pathog· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials.
Christopher L Cooper, Gavin Morrow, Maoli Yuan, John W Coleman, Fuxiang Hou, Christopher L Parks

Vaccines (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
Amy S Espeseth, Maoli Yuan, Michael Citron, Lucia Reiserova, Gavin Morrow, Christopher L Parks

EBioMedicine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques.
Nuria Pedreño-Lopez, Brandon C Rosen, Walter J Flores, Matthew J Gorman, Thomas B Voigt, Christopher L Parks

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.
Mauricio A Martins, Lucas Gonzalez-Nieto, Michael J Ricciardi, Varian K Bailey, Christine M Dang, Christopher L Parks

J Virol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in Rhesus Macaques.
Mauricio A Martins, Lucas Gonzalez-Nieto, Young C Shin, Aline Domingues, Martin J Gutman, Christopher L Parks

J Virol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Rhesus Macaques Vaccinated with , , and Manifest Early Control of SIVmac239 Replication.
Mauricio A Martins, Damien C Tully, Núria Pedreño-Lopez, Benjamin von Bredow, Matthias G Pauthner, Christopher L Parks

J Virol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.
Mauricio A Martins, Young C Shin, Lucas Gonzalez-Nieto, Aline Domingues, Martin J Gutman, Christopher L Parks

PLoS Pathog· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
Julien Nyombayire, Omu Anzala, Brian Gazzard, Etienne Karita, Philip Bergin, Christopher L Parks

J Infect Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.
Mauricio A Martins, Damien C Tully, Michael A Cruz, Karen A Power, Marlon G Veloso de Santana, Christopher L Parks

J Virol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein.
Xinsheng Zhang, Olivia L Wallace, Arban Domi, Kevin J Wright, Jonathan Driscoll, Christopher L Parks

Virology· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.
Svetlana Rabinovich, Rebecca L R Powell, Ross W B Lindsay, Maoli Yuan, Alexei Carpov, Christopher L Parks

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a duplex real-time RT-qPCR assay to monitor genome replication, gene expression and gene insert stability during in vivo replication of a prototype live attenuated canine distemper virus vector encoding SIV gag.
John W Coleman, Kevin J Wright, Olivia L Wallace, Palka Sharma, Heather Arendt, Christopher L Parks

J Virol Methods· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties.
Ivo C Lorenz, Hanh T Nguyen, Marina Kemelman, Ross W Lindsay, Maoli Yuan, Christopher L Parks

AIDS Res Hum Retroviruses· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing parallel induction of HIV type 1-specific antibody and T-cell responses by multicomponent subunit vaccines.
Genevieve Clutton, Alexei Carpov, Christopher L Parks, Hansi J Dean, David C Montefiori

AIDS· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.
Mauricio A Martins, Nancy A Wilson, Shari M Piaskowski, Kim L Weisgrau, Jessica R Furlott, Christopher L Parks

J Virol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.
David K Clarke, Farooq Nasar, Siew Chong, J Erik Johnson, John W Coleman, Christopher L Parks

J Virol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane-bound SIV envelope trimers are immunogenic in ferrets after intranasal vaccination with a replication-competent canine distemper virus vector.
Xinsheng Zhang, Olivia Wallace, Kevin J Wright, Martin Backer, John W Coleman, Christopher L Parks

Virology· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12.
Ross W Lindsay, Ian Ouellette, Heather E Arendt, Jennifer Martinez, Joanne DeStefano, Christopher L Parks

Vaccine· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of replication-competent viral vectors for HIV vaccine delivery.
Christopher L Parks, Louis J Picker, C Richter King

Curr Opin HIV AIDS· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis